FI20011560A0 - Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet - Google Patents
Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteetInfo
- Publication number
- FI20011560A0 FI20011560A0 FI20011560A FI20011560A FI20011560A0 FI 20011560 A0 FI20011560 A0 FI 20011560A0 FI 20011560 A FI20011560 A FI 20011560A FI 20011560 A FI20011560 A FI 20011560A FI 20011560 A0 FI20011560 A0 FI 20011560A0
- Authority
- FI
- Finland
- Prior art keywords
- alpha
- prevention
- treatment
- compounds useful
- mediated disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Priority Applications (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011560A FI116940B (fi) | 2001-07-20 | 2001-07-20 | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
| ARP020102661A AR036173A1 (es) | 2001-07-20 | 2002-07-16 | Compuesto de bencenosulfonamida y su uso en la elaboracion de una preparacion util para el tratamiento o la prevencion de una enfermedad mediada por el alfa-2b-adrenoceptor |
| PE2002000634A PE20030587A1 (es) | 2001-07-20 | 2002-07-17 | DERIVADOS DE PIRIMIDINA BENCENOSULFONAMIDA COMO ANTAGONISTAS DE ALFA-2ß-ADRENORECEPTOR |
| US10/196,123 US6767909B2 (en) | 2001-07-20 | 2002-07-17 | Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor |
| MXPA04000615A MXPA04000615A (es) | 2001-07-20 | 2002-07-22 | Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor. |
| IL15951102A IL159511A0 (en) | 2001-07-20 | 2002-07-22 | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| HU0401076A HUP0401076A2 (hu) | 2001-07-20 | 2002-07-22 | Alfa-2B-andrenoceptor antagonista vegyületek és alkalmazásuk gyógyszerkészítmények előállítására |
| KR10-2004-7001043A KR20040030850A (ko) | 2001-07-20 | 2002-07-22 | 알파-2비-아드레노셉터 매개 질병의 치료 및 예방에유용한 화합물 |
| PL02367040A PL367040A1 (en) | 2001-07-20 | 2002-07-22 | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| CNA02814595XA CN1753877A (zh) | 2001-07-20 | 2002-07-22 | 用于治疗或预防α－2B－肾上腺素受体介导疾病的化合物 |
| EP02748902A EP1417182A1 (en) | 2001-07-20 | 2002-07-22 | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| PCT/FI2002/000643 WO2003008387A1 (en) | 2001-07-20 | 2002-07-22 | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| NZ530366A NZ530366A (en) | 2001-07-20 | 2002-07-22 | Compounds useful for treatment or prevention of disease mediated by alpha-2B-adrenoceptor |
| RU2004105035/04A RU2004105035A (ru) | 2001-07-20 | 2002-07-22 | Соединения, полезные для лечения или профилактики заболевания, опосредованного альфа-2b-адреноцептором |
| CA002454187A CA2454187A1 (en) | 2001-07-20 | 2002-07-22 | Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| JP2003513947A JP2004535467A (ja) | 2001-07-20 | 2002-07-22 | α−２Ｂ−アドレナリン受容体が介在する疾患を治療又は予防するために有用な化合物 |
| NO20040237A NO20040237L (no) | 2001-07-20 | 2004-01-19 | Forbindelser anvendelige for behandling eller forbygging av sykdom overført via alfa-2B-adrenoceptor |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011560A FI116940B (fi) | 2001-07-20 | 2001-07-20 | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
| FI20011560 | 2001-07-20 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI20011560A0 true FI20011560A0 (fi) | 2001-07-20 |
| FI20011560A FI20011560A (fi) | 2003-01-21 |
| FI116940B FI116940B (fi) | 2006-04-13 |
Family
ID=8561670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20011560A FI116940B (fi) | 2001-07-20 | 2001-07-20 | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6767909B2 (fi) |
| KR (1) | KR20040030850A (fi) |
| CN (1) | CN1753877A (fi) |
| AR (1) | AR036173A1 (fi) |
| FI (1) | FI116940B (fi) |
| PE (1) | PE20030587A1 (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7615563B2 (en) * | 2003-08-08 | 2009-11-10 | Gonzalez Iii Jesus E | Compositions useful as inhibitors of voltage-gated sodium channels |
| JP2007501804A (ja) * | 2003-08-08 | 2007-02-01 | バーテックス ファーマシューティカルズ インコーポレイテッド | 電位開口型のナトリウムチャネルのインヒビターとして有用な組成物 |
| FI118265B (fi) * | 2004-01-15 | 2007-09-14 | Jurilab Ltd Oy | Menetelmä akuutin sydäninfarktin ja sepelvaltimotaudin riskin havaitsemiseksi |
| AU2007318922C1 (en) | 2006-11-07 | 2013-09-12 | Proteologics Ltd. | Pyrimidine derivatives as POSH and POSH-AP inhibitors |
| CA2926950C (en) | 2013-10-10 | 2022-10-11 | Eastern Virginia Medical School | 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase |
| CN104189909B (zh) * | 2014-09-18 | 2017-04-12 | 中国人民解放军第三军医大学 | 肾上腺素受体拮抗剂在制备缓解脑损伤引起钠电流增加的药物中应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2086544C1 (ru) | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина |
| US6150389A (en) | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
| PL357872A1 (en) | 2000-02-11 | 2004-07-26 | Oy Juvantia Pharma Ltd | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| US6521632B2 (en) | 2000-02-11 | 2003-02-18 | Oy Juvantia Pharma Ltd | Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor |
-
2001
- 2001-07-20 FI FI20011560A patent/FI116940B/fi not_active IP Right Cessation
-
2002
- 2002-07-16 AR ARP020102661A patent/AR036173A1/es unknown
- 2002-07-17 US US10/196,123 patent/US6767909B2/en not_active Expired - Fee Related
- 2002-07-17 PE PE2002000634A patent/PE20030587A1/es not_active Application Discontinuation
- 2002-07-22 KR KR10-2004-7001043A patent/KR20040030850A/ko not_active Application Discontinuation
- 2002-07-22 CN CNA02814595XA patent/CN1753877A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PE20030587A1 (es) | 2003-07-08 |
| FI20011560A (fi) | 2003-01-21 |
| FI116940B (fi) | 2006-04-13 |
| AR036173A1 (es) | 2004-08-18 |
| KR20040030850A (ko) | 2004-04-09 |
| US6767909B2 (en) | 2004-07-27 |
| US20030073710A1 (en) | 2003-04-17 |
| CN1753877A (zh) | 2006-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
| CY2015003I1 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| NO20035156D0 (no) | Fremgangsmåter for brönnbehandling | |
| NO20034590L (no) | Fremgangsmåter for behandling av vaskul¶r sykdom | |
| DE60219292D1 (de) | Pyrazolderivate zur behandlung von hiv | |
| NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| ATE355026T1 (de) | Einstellbarer fixateur | |
| PT1154777E (pt) | Medicamento para o tratamento de hipertensao arterial | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| DE60223576D1 (de) | Hautbehandlungszusammensetzung | |
| DE60236743D1 (de) | Zur behandlung androgenabhängiger krankheiten | |
| ATE389742T1 (de) | Gewebebehandlungsmittel | |
| NO20033804D0 (no) | Karbamatforbindelser for behandling av smerte | |
| FR2860154B1 (fr) | Composition pour le traitement de la mauvaise haleine | |
| DE60220220D1 (de) | Blutbehandlungssystem | |
| EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
| ATE374011T1 (de) | Hautbehandlungsmittel | |
| DE60227963D1 (de) | Behandlungssystem | |
| FI20011560A0 (fi) | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet | |
| NO20033341D0 (no) | Metoder for administrering av epothilone-analoger for behandling av kreft | |
| NO20042476L (no) | Anvendelse av desoxypeganin for behandling av klinisk depresjon | |
| NO20043113L (no) | Fremgangsmate for behandling av benforstyrrelse | |
| FI20000303A0 (fi) | Alfa-2B-adrenoseptorivälitteisen sairauden hoitoon tai ehkäisyyn käyttökelpoiset yhdisteet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Ref document number: 116940 Country of ref document: FI |
|
| MA | Patent expired |